STAT March 18, 2025
Feng Zhang spinoff has clearance to start gene editing clinical trial
Three years ago, Arbor Biotechnologies CEO Devyn Smith appeared at the J.P. Morgan Healthcare Conference and laid out a grand vision: With $215 million in new capital, the...